Genome-wide association studies (GWAS) have shown that many genes, such as TREM2, CR1, CD33, SPI1 (PU.1), EPHA1, and MS4A4A/MS4A6A, increase AD risk and are related to the immune system[19–22]. Here, CD33 is linked to Alzheimer disease.